The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
Chronic infection with HIV type 1 is associated with alterations in macronutrient metabolism, specifically elevated plasma lipids, glucose and reduced insulin sensitivity. These alterations are most severe in patients at the later stages of AIDS, indicating a relationship with disease progression. Recently, a metabolic syndrome, termed lipodystrophy, has been described in successfully-treated HIV patients in whom the altered macronutrient metabolism of HIV infection appears to be amplified markedly, with concurrent alterations in adipose tissue patterning. This syndrome presents a paradox, as before the development of highly-active antiretroviral therapy (HAART) the most severe perturbations in metabolism were observed in the sickest patients. Now, the patients that respond well to therapy are showing metabolic perturbations much greater than those seen before. The implications of this syndrome are that, whilst life expectancy may be increased by reducing viral load, there are concomitant increases in the risk of cardiovascular disease, diabetes and pancreatitis within this patient population. The aetiology of the syndrome remains unclear. In a collaborative trial with the Chelsea and Westminster Hospital in London we have used stable-isotope-labelled fatty acids to examine the hypothesis that treatment with HAART causes a delayed clearance of dietary lipid from the circulation, resulting in the retention of lipid within plasma and the downstream changes in insulin and glucose homeostasis. This hypothesis would indicate a role for low-fat diets, exercise and drugs that reduce plasma lipid or insulin resistance, in modulating the response to antiretroviral therapy in HIV infection.
lipodystrophy, hiv, metabolism, lipids, stable isotopes
131-136
Ware, Lisa J.
74860e6c-ac74-44ae-bb62-a7a2032852ba
Wootton, S. A.
bf47ef35-0b33-4edb-a2b0-ceda5c475c0c
Morlese, J.M.
4a2f2445-7be2-4687-94f5-d30612887442
Gazzard, B.G.
1944c632-54e0-4fca-94eb-a81f61942684
Jackson, A.A.
c9a12d7c-b4d6-4c92-820e-890a688379ef
February 2002
Ware, Lisa J.
74860e6c-ac74-44ae-bb62-a7a2032852ba
Wootton, S. A.
bf47ef35-0b33-4edb-a2b0-ceda5c475c0c
Morlese, J.M.
4a2f2445-7be2-4687-94f5-d30612887442
Gazzard, B.G.
1944c632-54e0-4fca-94eb-a81f61942684
Jackson, A.A.
c9a12d7c-b4d6-4c92-820e-890a688379ef
Ware, Lisa J., Wootton, S. A., Morlese, J.M., Gazzard, B.G. and Jackson, A.A.
(2002)
The paradox of improved antiretroviral therapy in HIV: potential for nutritional modulation?
Proceedings of the Nutrition Society, 61 (1), .
(doi:10.1079/PNS2001139).
(PMID:12002787)
Abstract
Chronic infection with HIV type 1 is associated with alterations in macronutrient metabolism, specifically elevated plasma lipids, glucose and reduced insulin sensitivity. These alterations are most severe in patients at the later stages of AIDS, indicating a relationship with disease progression. Recently, a metabolic syndrome, termed lipodystrophy, has been described in successfully-treated HIV patients in whom the altered macronutrient metabolism of HIV infection appears to be amplified markedly, with concurrent alterations in adipose tissue patterning. This syndrome presents a paradox, as before the development of highly-active antiretroviral therapy (HAART) the most severe perturbations in metabolism were observed in the sickest patients. Now, the patients that respond well to therapy are showing metabolic perturbations much greater than those seen before. The implications of this syndrome are that, whilst life expectancy may be increased by reducing viral load, there are concomitant increases in the risk of cardiovascular disease, diabetes and pancreatitis within this patient population. The aetiology of the syndrome remains unclear. In a collaborative trial with the Chelsea and Westminster Hospital in London we have used stable-isotope-labelled fatty acids to examine the hypothesis that treatment with HAART causes a delayed clearance of dietary lipid from the circulation, resulting in the retention of lipid within plasma and the downstream changes in insulin and glucose homeostasis. This hypothesis would indicate a role for low-fat diets, exercise and drugs that reduce plasma lipid or insulin resistance, in modulating the response to antiretroviral therapy in HIV infection.
This record has no associated files available for download.
More information
Published date: February 2002
Keywords:
lipodystrophy, hiv, metabolism, lipids, stable isotopes
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 383834
URI: http://eprints.soton.ac.uk/id/eprint/383834
ISSN: 0029-6651
PURE UUID: bf495d8c-948c-4498-ac6d-284557c41c24
Catalogue record
Date deposited: 26 Nov 2015 11:47
Last modified: 14 Mar 2024 21:48
Export record
Altmetrics
Contributors
Author:
Lisa J. Ware
Author:
J.M. Morlese
Author:
B.G. Gazzard
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics